{"organizations": [], "uuid": "bd1053ae7eeeb7703ceae5f42ccb0d61ad5279fd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/europe", "section_title": "European Stock Market News | Reuters.com", "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-helsinn-g/brief-glenmark-pharmaceuticals-helsinn-group-enter-into-agreement-for-launch-of-akynzeo-in-india-and-nepal-idUSFWN1RH011", "country": "US", "domain_rank": 408, "title": "BRIEF-Glenmark Pharmaceuticals, Helsinn Group Enter Into Agreement For Launch Of Akynzeo In India And Nepal", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.286, "site_type": "news", "published": "2018-04-04T16:45:00.000+03:00", "replies_count": 0, "uuid": "bd1053ae7eeeb7703ceae5f42ccb0d61ad5279fd"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-helsinn-g/brief-glenmark-pharmaceuticals-helsinn-group-enter-into-agreement-for-launch-of-akynzeo-in-india-and-nepal-idUSFWN1RH011", "ord_in_thread": 0, "title": "BRIEF-Glenmark Pharmaceuticals, Helsinn Group Enter Into Agreement For Launch Of Akynzeo In India And Nepal", "locations": [], "entities": {"persons": [], "locations": [{"name": "nepal", "sentiment": "none"}, {"name": "india", "sentiment": "none"}, {"name": "nepal", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-glenmark pharmaceuticals", "sentiment": "negative"}, {"name": "glenmark pharmaceuticals ltd", "sentiment": "negative"}, {"name": "helsinn group enter into agreement for launch of akynzeo in india", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 4 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* SAYS CO, HELSINN GROUP ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR LAUNCH OF AKYNZEO IN INDIA AND NEPAL\n* SAYS CO WILL HAVE EXCLUSIVE MARKETING RIGHTS FOR AKYNZEO IN INDIA AND NEPAL. Source text - bit.ly/2q38jOE Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "http://bit.ly/2q38jOE"], "published": "2018-04-04T16:45:00.000+03:00", "crawled": "2018-04-04T13:55:23.004+03:00", "highlightTitle": ""}